Rigel Pharmaceuticals, Inc. (RIGL)

34.74 -0.97 (-2.72%) USD  |  NASDAQ  |  Feb 27, 16:00
34.70 -0.04 (-0.12%) After-Hours: 20:00
More

Rigel Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Eli Lilly & Co. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade